Sensorion to launch gene therapy trial of SENS-501 for hearing loss in France
Sensorion, a leading clinical-stage biotechnology company, has achieved a major milestone in the field of audiology and genetic research. The company has received approval for its Clinical Trial Application (CTA) in France to commence a Phase 1/2 trial of its groundbreaking gene therapy, SENS-501. This clinical trial, named Audiogene, is poised to explore the potential […]